## Anatomical Diagnosis

The t(6;11) *TFEB* translocation variant of renal-cell carcinoma. 

This case was presented at Urology Grand Rounds, in association with the American Urology Association 2017 meeting in Boston.

Dr. Iliopoulos reports holding a patent on metabolic gene, enzyme, and flux targets for cancer therapy and holding patents and pending patents on hypoxia-inducible factor inhibitors. No other potential conflict of interest relevant to this article was reported.

Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.

We thank Dr. Michael Blute for assistance with preparation of the case.